Stilwell McDavid 4
4 · Coherus BioSciences, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Stilwell McDavid
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-12-31$3.33/sh−18,440$61,405→ 75,305 total
Footnotes (2)
- [F1]Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
- [F2]Includes 4,826 shares acquired on November 15, 2023, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan and includes the cancellation of 13,333 restricted stock units.